JLE

Epileptic Disorders

MENU

The epilepsy-movement disorder phenotypic spectrum and phenytoin-induced dyskinesia associated with GABRB3 pathogenic variants Volume 23, numéro 6, December 2021

  • [1] Møller R.S., Wuttke T.V., Helbig I., Marini C., Johannesen K.M., Brilstra E.H. Mutations in GABRB3 From febrile seizures to epileptic encephalopathies. Neurology. 2017;88:483-492. 5
  • [2] Hernandez C.C., Klassen T.L., Jackson L.G., Gurba K., Hu N., Noebels J.L. Deleterious rare variants reveal risk for loss of gabaa receptor function in patients with genetic epilepsy and in the general population. PLoS One. 2016;11:e0162883. 9
  • [3] Papandreou A., Danti F.R., Spaull R., Leuzzi V., Mctague A., Kurian M.A. The expanding spectrum of movement disorders in genetic epilepsies. Dev Med Child Neurol. 2020;62:178-191.
  • [4] Burgess R., Wang S., McTague A., Boysen K.E., Yang X., Zeng Q. The genetic landscape of epilepsy of infancy with migrating focal seizures. Ann Neurol. 2019;86:821-831. 6
  • [5] McTague A., Howell K.B., Cross J.H., Kurian M.A., Scheffer I.E. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016;15:304-316. 3
  • [6] Pavone P., Pappalardo X.G., Marino S.D., Sciuto L., Corsello G., Ruggieri M. A novel GABRB3 variant in Dravet syndrome: case report and literature review. Mol Genet Genomic Med. 2020;8:e1461. 11
  • [7] Shi Y.W., Zhang Q., Cai K., Poliquin S., Shen W., Winters N. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes. Brain. 2019;142:3028-3044. 10
  • [8] Montenegro M.A., Scotoni A.E., Cendes F. Dyskinesia induced by phenytoin. Arq Neuropsiquiatr. 1999;57:356-360. 2-B
  • [9] Chalhub E.G., Devivo D.C., Volpe J.J. Phenytoin-induced dystonia and choreoathetosis in two retarded epileptic children. Neurology. 1976;26:494-498.
  • [10] Harrison M.B., Lyons G.R., Landow E.R. Phenytoin and dyskinesias: a report of two cases and review of the literature. Mov Disord. 1993;8:19-27. 1